(Q59649521)
Statements
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome (English)
C Pozzilli
F D'Andrea
S Morino
V B Morra
A Bozzao
A Calo'
M L Bernini
D Gambi